CD68 tumor-associated macrophage marker is not prognostic of clinical outcome in classical Hodgkin lymphoma

Author： Kayal Smita Mathur Sandeep Karak Asis K. Kumar Lalit Sharma Atul Bakhshi Sameer Raina Vinod

ISSN： 1042-8194

Source： Leukemia and Lymphoma, Vol.55, Iss.5, 2014-05, pp. : 1031-1037

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

High-grade Non-Hodgkin's Lymphoma Treated in Northern Norway: Treatment, Outcome, and Prognostic Factors

By Bremnes Roy Martin Bremnes Yngve Dønnem Tom

Acta Oncologica, Vol. 38, Iss. 1, 1999-02 ,pp. : 117-124

Informa Healthcare

Access to resources Recommend Favorite

The prognostic significance of tumor-associated stroma in invasive breast carcinoma

By Ahn Soomin

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1573-1580

Springer Publishing Company

Access to resources Recommend Favorite

Application of MALDI imaging for the diagnosis of classical Hodgkin lymphoma

By Schwamborn Kristina Krieg René Jirak Peggy Ott German Knüchel Ruth Rosenwald Andreas Wellmann Axel

Journal of Cancer Research and Clinical Oncology, Vol. 136, Iss. 11, 2010-11 ,pp. : 1651-1655

Springer Publishing Company

Access to resources Recommend Favorite

Interim positron emission tomography and clinical outcome in patients with early stage Hodgkin lymphoma treated with combined modality therapy

By Filippi Andrea Riccardo

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1183-1187

Informa Healthcare

Access to resources Recommend Favorite

Clinical pretreatment risk factors and prediction of outcome using gallium 67 scintigraphy in patients with Hodgkin's lymphoma

Molecular and Clinical Oncology, Vol. 4, Iss. 1, 2016-01 ,pp. : 93-99

Science Publishers

Access to resources Recommend Favorite